Interference of Aspergillus fumigatus with the immune response

Thorsten Heinekamp1, Hella Schmidt, Katrin Lapp

  • 1Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Jena, Germany, thorsten.heinekamp@hki-jena.de.

Seminars in Immunopathology
|November 19, 2014
PubMed

Insights

Aspergillus fumigatus, a common airborne fungus, causes diseases ranging from allergies to life-threatening infections by evading the human immune system. Understanding its immune evasion strategies is crucial for developing new diagnostic and therapeutic approaches.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Aspergillus fumigatus is a prevalent airborne fungal pathogen causing diverse diseases based on host immunity.
  • It ranges from allergies in immunocompetent individuals to invasive infections in immunocompromised patients.
  • Unlike most Aspergillus species, A. fumigatus possesses virulence factors enabling infection establishment.

Purpose of the Study:

  • To summarize the immune evasion strategies employed by Aspergillus fumigatus.
  • To discuss the role of virulence determinants in fungal pathogenesis.
  • To explore the potential of immunoproteomics in improving diagnosis and therapy.

Main Methods:

  • Review of scientific literature on Aspergillus fumigatus virulence and host immune interactions.
  • Analysis of mechanisms used by the fungus to evade complement system and phagocytic cells.
  • Discussion of recent advancements in immunoproteomics relevant to fungal infections.

Main Results:

  • A. fumigatus employs multiple strategies to evade host immunity, including interference with complement regulators.
  • The fungus actively manipulates lung epithelial cells, macrophages, and neutrophils to prevent immune clearance.
  • Virulence factors are key to A. fumigatus establishing infections.

Conclusions:

  • Aspergillus fumigatus utilizes sophisticated mechanisms to subvert host immune responses.
  • Advances in immunoproteomics offer promising avenues for enhanced diagnosis and treatment of A. fumigatus infections.
  • Further research into fungal immune evasion is critical for clinical management.

Related Concept Videos

Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
2.5K
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
106
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
88.7K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.7K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
647
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
393